TRCSX
Price
$17.38
Change
-$0.11 (-0.63%)
Updated
Oct 17 closing price
Net Assets
290.81M
VSMAX
Price
$121.32
Change
-$0.03 (-0.02%)
Updated
Oct 17 closing price
Net Assets
162.36B
Interact to see
Advertisement

TRCSX vs VSMAX

Header iconTRCSX vs VSMAX Comparison
Open Charts TRCSX vs VSMAXBanner chart's image
T. Rowe Price Small-Cap Index I
Price$17.38
Change-$0.11 (-0.63%)
VolumeN/A
Net Assets290.81M
Vanguard Small Cap Index Admiral Shares
Price$121.32
Change-$0.03 (-0.02%)
VolumeN/A
Net Assets162.36B
TRCSX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
TRCSX vs. VSMAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRCSX is a Hold and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 162B vs. TRCSX (291M). VSMAX (1.34) and TRCSX (1.34) have matching dividends . TRCSX was incepted earlier than VSMAX: TRCSX (10 years) vs VSMAX (25 years). TRCSX (0.31) is less costly to investors than VSMAX (0.05). TRCSX is a more actively managed with annual turnover of: 24.70 vs. VSMAX (13.00). VSMAX has a lower initial minimum investment than TRCSX: VSMAX (3000) vs TRCSX (500000). TRCSX annual gain was more profitable for investors over the last year : 7.11 vs. VSMAX (4.95). VSMAX return over 5 years is better than : 55.46 vs. TRCSX (51.28).
TRCSXVSMAXTRCSX / VSMAX
Total Expense Ratio0.140.05280%
Annual Report Gross Expense Ratio0.310.05620%
Fund Existence10 years25 years-
Gain YTD11.0545.599197%
Front LoadN/AN/A-
Min. Initial Investment500000300016,667%
Min. Initial Investment IRAN/AN/A-
Net Assets291M162B0%
Annual Yield % from dividends1.341.34100%
Returns for 1 year7.114.95144%
Returns for 3 years43.2242.02103%
Returns for 5 years51.2855.4692%
Returns for 10 yearsN/A130.86-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYRE22.470.23
+1.03%
Spyre Therapeutics
DVA125.880.63
+0.50%
DaVita
HVIIU10.71N/A
N/A
Hennessy Capital Investmnt Corp VII
CIVB19.97-0.03
-0.15%
Civista Bancshares
LUNG1.52-0.05
-3.18%
Pulmonx Corp